CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.0052 USD 6.12% Market Closed
Market Cap: 3.4m USD

Gross Margin
CannaPharmaRx Inc

-160.2%
Current
-315%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-160.2%
=
Gross Profit
-2.2m
/
Revenue
1.4m

Gross Margin Across Competitors

No Stocks Found

CannaPharmaRx Inc
Glance View

Market Cap
3.4m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.0042 USD
Overvaluation 19%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-160.2%
=
Gross Profit
-2.2m
/
Revenue
1.4m
What is the Gross Margin of CannaPharmaRx Inc?

Based on CannaPharmaRx Inc's most recent financial statements, the company has Gross Margin of -160.2%.

Back to Top